Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences - PubMed (original) (raw)

Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences

Peter M Fayers et al. Qual Life Res. 2014 Feb.

Abstract

Minimal important differences (MIDs) for patient-reported outcomes (PROs) are often estimated by selecting a clinical variable to serve as an anchor. Then, differences in the clinical anchor regarded as clinically meaningful or important can be used to estimate the corresponding value of the PRO. Although these MID values are sometimes estimated by regression techniques, we show that this is a biased procedure and should not be used; alternative methods are proposed.

PubMed Disclaimer

References

    1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Controlled Clinical Trials. 1989;10:407–415. -PubMed
    1. US Food and Drug Administration Patient-reported outcome measures: Use in medical product development to support labeling claims. Guidance for industry. 2009 http://www.fda.gov/down loads/Drugs/GuidanceComplianceRegulatoryInformat.... Accessed March 20, 2013. -PMC -PubMed
    1. McLeod LD, Coon CD, Martin S, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: FDA guidance and emerging methods. Expert Review of Pharmacoeconomics and Outcomes Research. 2011;11:163–169. -PMC -PubMed
    1. Kvam AK, Wisløff F, Fayers PM. Minimal important differences and response shift in health-related quality of life; A longitudinal study in patients with multiple myeloma. Health and Quality of Life Outcomes. 2010;8:79. -PMC -PubMed
    1. Schwartz N, Sudman S. Autobiographical memory and the validity of retrospective reports. Springer; New York: 1994.

Publication types

MeSH terms

LinkOut - more resources